These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10861501)

  • 21. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.
    Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 2002 Aug; 119(2):499-506. PubMed ID: 12190876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
    Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
    Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
    Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
    Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily.
    Mitsuhiro MR; Eguchi S; Yamashita H
    Acta Ophthalmol Scand; 2003 Dec; 81(6):630-8. PubMed ID: 14641267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and localization of the transforming growth factor-beta type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats.
    Park DY; Lee CH; Sol MY; Suh KS; Yoon SY; Kim JW
    J Korean Med Sci; 2003 Aug; 18(4):510-9. PubMed ID: 12923327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
    Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
    Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
    Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
    Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.
    Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A
    J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone.
    Horner A; Kemp P; Summers C; Bord S; Bishop NJ; Kelsall AW; Coleman N; Compston JE
    Bone; 1998 Aug; 23(2):95-102. PubMed ID: 9701467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-beta target gene expression.
    Kanzaki M; Shibagaki N; Hatsushika K; Mitsui H; Inozume T; Okamoto A; Dobashi Y; Ogawa H; Shimada S; Nakao A
    Int Arch Allergy Immunol; 2007; 142(4):309-17. PubMed ID: 17135762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
    Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
    Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
    Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
    Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
    EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.